Jul 1 |
PTC Therapeutics (PTCT) Down on Negative CHMP Opinion on DMD Drug
|
Jun 28 |
Biggest stock movers today: PLUG, NKE, DJT, and more
|
Jun 28 |
PTC Therapeutics Tumbles After European Regulators Reject Its Drug — Again
|
Jun 28 |
PTC faces another Duchenne drug rejection; Coherus sells Humira biosimilar
|
Jun 28 |
PTC drops as EU panel declines to recommend Translarna marketing renewal
|
Jun 28 |
CHMP Issues Negative Opinion on Translarna™ Following European Commission Request for Review
|
Jun 24 |
PTC Therapeutics (PTCT) Soars 9.7%: Is Further Upside Left in the Stock?
|
Jun 20 |
PTC Therapeutics says FDA lifted partial hold on Huntington's disease program
|
Jun 20 |
PTC Therapeutics Says FDA Lifts Clinical Hold On Investigational Study In Patients With Rare Weak Nerve Cell Disorder
|
Jun 20 |
FDA lifts hold on PTC Huntington’s disease trial
|